Efficacy and safety of canagliflozin in kidney transplant patients
نویسندگان
چکیده
منابع مشابه
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
AIMS Canagliflozin is a sodium glucose co-transporter 2 inhibitor in development for treatment of type 2 diabetes mellitus (T2DM). This study evaluated the efficacy and safety of canagliflozin in subjects with T2DM and stage 3 chronic kidney disease [CKD; estimated glomerular filtration rate (eGFR) ≥30 and <50 ml/min/1.73 m(2)]. METHODS In this randomized, double-blind, placebo-controlled, ph...
متن کاملThe effect of family-centered empowerment model on quality of life and self-efficacy of kidney transplant patients in 2018
Background: Quality of life is a mental issue that causes a person to be affected by various factors including self-efficacy. The roadmap in this field is family-centered empowerment, which aims to promote health. The aim of this study was to determine the effect of family-centered empowerment model on quality of life and self-efficacy of kidney transplant patients. Materials and Method: This...
متن کاملASSESSMENT OF QUALITY OF LIFE IN 50 PATIENTS WHILE UNDER HEMODIALYSIS AND FOLLOWING KIDNEY TRANSPLANT
The quality of life of 50 end stage renal disease (ESRD) patients on hemodialysis was evaluated before and after kidney transplantation (KTx). Mean duration of the patients' hemodialysis was 3 years and mean postoperative period was 2.4 years when tested. Common problems of such patients such as depression, sleep disorders, energy pattern disruption, sex-life difficulties, and appetite dis...
متن کاملEfficacy and safety of canagliflozin in patients with type 2 diabetes mellitus living in hot climates
AIMS Patients with type 2 diabetes mellitus (T2DM) have increased risk of adverse events (AEs; e.g. dehydration, hypoglycaemia) in hot weather. This analysis assessed the efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, in patients with T2DM who live in hot climates. METHODS This post hoc analysis evaluated patients with T2DM using pooled data from fo...
متن کاملEfficacy and safety of canagliflozin in patients with type 2 diabetes
BACKGROUND Canagliflozin is a new SGLT2 inhibitor which has been approved as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes (T2D) mellitus in more than 30 countries. To evaluate the efficacy and safety of canagliflozin in patients with T2D, we carried out a meta-analysis of phase III clinical trials to offer an additional evidence of the efficacy and safety of ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Nephrology
سال: 2019
ISSN: 0971-4065
DOI: 10.4103/ijn.ijn_2_18